400
Participants
Start Date
March 28, 2019
Primary Completion Date
December 8, 2021
Study Completion Date
February 14, 2022
Bimekizumab
Subjects will receive bimekizumab at pre-specified time-points.
Placebo
Subjects will receive placebo at pre-specified time-points.
Pa0011 50011, New York
Pa0011 50010, Brooklyn
Pa0011 50034, Rochester
Pa0011 50020, Duncansville
Pa0011 50064, Philadelphia
Pa0011 50006, Wyomissing
Pa0011 50026, Wheaton
Pa0011 50015, Hagerstown
Pa0011 50050, Beckley
Pa0011 50031, Salisbury
Pa0011 50125, Charlotte
Pa0011 50021, Summerville
Pa0011 50039, Atlanta
Pa0011 50037, Tampa
Pa0011 50033, Palm Harbor
Pa0011 50001, Jackson
Pa0011 50028, Lexington
Pa0011 50040, Vandalia
Pa0011 50019, Lansing
Pa0011 50016, St Louis
Pa0011 50023, Baton Rouge
Pa0011 50036, Mesquite
Pa0011 50009, Waco
Pa0011 50002, Austin
Pa0011 50024, Boise
Pa0011 50017, Phoenix
Pa0011 50029, Albuquerque
Pa0011 50035, San Diego
Pa0011 50004, Tustin
Pa0011 50047, Boston
Pa0011 50005, Freehold
Pa0011 50008, Johnston
Pa0011 50012, Memphis
Pa0011 30005, Camberwell
Pa0011 30007, Victoria Park
Pa0011 30006, Woodville South
Pa0011 50042, Rimouski
Pa0011 50043, Sydney
Pa0011 50044, Trois-Rivières
Pa0011 40009, Pardubice
Pa0011 40063, Prague
Pa0011 40066, Prague
Pa0011 40012, Zlín
Pa0011 40076, Cottbus
Pa0011 40023, Erlangen
Pa0011 40117, Frankfurt
Pa0011 40029, Hamburg
Pa0011 40071, Hamburg
Pa0011 40078, Leipzig
Pa0011 40026, Ratingen
Pa0011 40083, Budapest
Pa0011 40079, Szentes
Pa0011 40084, Catania
Pa0011 40087, Milan
Pa0011 40086, Reggio Emilia
Pa0011 20030, Chūōku
Pa0011 20043, Itabashi-ku
Pa0011 20036, Kawachi-Nagano
Pa0011 20045, Kita-gun
Pa0011 20049, Kitakyushu
Pa0011 20044, Minatoku
Pa0011 20041, Osaka
Pa0011 20046, Osaka
Pa0011 20031, Sapporo
Pa0011 20042, Sasebo
Pa0011 20032, Suita
Pa0011 40119, Bydgoszcz
Pa0011 40038, Elblag
Pa0011 40037, Lublin
Pa0011 40091, Nowa Sól
Pa0011 40044, Poznan
Pa0011 40090, Poznan
Pa0011 40118, Torun
Pa0011 40041, Warsaw
Pa0011 40097, Warsaw
Pa0011 40098, Warsaw
Pa0011 40039, Wroclaw
Pa0011 40043, Wroclaw
Pa0011 20005, Korolyov
Pa0011 20010, Moscow
Pa0011 20013, Petrozavodsk
Pa0011 20001, Saint Petersburg
Pa0011 20004, Saint Petersburg
Pa0011 20009, Saint Petersburg
Pa0011 20007, Saratov
Pa0011 20014, Ulyanovsk
Pa0011 20006, Vladimir
Pa0011 20008, Yaroslavl
Pa0011 20015, Yaroslavl
Pa0011 40111, Bradford
Pa0011 40109, Oxford
Pa0011 40116, Stamford
UCB Biopharma SRL
INDUSTRY